Viking Therapeutics (VKTX) Stock: Next Stop, $28?
Investors love biotech stocks for the lottery ticket-like returns they can offer if a company …
Analysts Bet Trevena’s (TRVN) Pain Management Drug Will Get FDA Approval
Every month brings plenty of catalysts for several biotech stocks. October is no exception. There …
This Analyst Just Doubled His Price Target on Viking Therapeutics (VKTX) Stock; Here’s Why
It’s a very rewarding trading day for investors in Viking Therapeutics (VKTX) with shares up …
Here’s Why Teva Pharmaceutical (TEVA) Stock Soared Today
There’s a new FDA-approved migraine treatment on the scene. On Friday night, the U.S. regulators green-lighted …
Maxim Stays Bullish on Atossa (ATOS) Stock Following Preliminary Phase 1 Results
In a research note issued Thursday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares …
J.P. Morgan Cuts Price Target on Acorda (ACOR) Stock Following Negative Ruling on Ampyra Patent
Did an iceberg just wallop into Acorda (ACOR) stock? The drug maker’s shares are plunging at …
Oppenheimer Shares Two Cents on Verastem (VSTM) Following Initiation of Phase I/II Duvelisib Study in Combination with Venetoclax
Yesterday, Verastem (VSTM) announced dosing of the first patient in a multicenter Phase I/II clinical trial …
H.C. Wainwright Reiterates Upbeat View of MannKind; Here’s Why
This week, MannKind (MNKD) announced a global partnership with United Therapeutics (UTHR) to develop and …
Is Sangamo’s (SGMO) Stock Price Collapse Justified?
Sangamo’s (NASDAQ:SGMO) shares lost over a quarter of their value in the past two days, …
Oppenheimer Reiterates Bullish Stance on TherapeuticsMD (TXMD) Following Business Update
TherapeuticsMD (NYSE:TXMD) CEO Robert Finizio and Co-founder Brian Bernick presented today at the 13th Annual Wells Fargo Securities …